Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Reexamination Certificate
2007-09-06
2009-06-16
Ouspenski, Ilia (Department: 1644)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
C424S133100, C424S135100, C424S143100, C424S144100, C530S388100, C530S387300, C530S388220
Reexamination Certificate
active
07547437
ABSTRACT:
Materials and methods for treating fibrosis in a mammal are disclosed. The methods comprise administering to a mammal a composition comprising a therapeutically effective amount of a zvegf3 antagonist in combination with a pharmaceutically acceptable delivery vehicle. Zvegf3 antagonists include anti-zvegf3 antibodies, mitogenically inactive receptor-binding zvegf3 variant polypeptides, and inhibitory polynucleotides. Within one embodiment of the invention the fibrosis is liver fibrosis.
REFERENCES:
patent: 5238950 (1993-08-01), Clader et al.
patent: 5700823 (1997-12-01), Hirth et al.
patent: 6432673 (2002-08-01), Gao et al.
patent: 6455283 (2002-09-01), Ferrara et al.
patent: 6528050 (2003-03-01), Gao et al.
patent: 6814965 (2004-11-01), Gao et al.
patent: 6887982 (2005-05-01), Gao et al.
patent: 6893637 (2005-05-01), Gilbertson
patent: 7147852 (2006-12-01), Gilbertson
patent: 2002/0004225 (2002-01-01), Hart et al.
patent: 2002/0164687 (2002-11-01), Eriksson et al.
patent: 2003/0087870 (2003-05-01), Gilbertson
patent: 2005/0159358 (2005-07-01), Gao et al.
patent: 2005/0191304 (2005-09-01), Palmer
patent: 0585242 (1999-08-01), None
patent: 99/46281 (1999-09-01), None
patent: 99/47677 (1999-09-01), None
patent: 00/34474 (2000-06-01), None
patent: 00/59940 (2000-10-01), None
Bergsten et al.,Nature Cell Biol.3: 512-516, 2001.
Brady et al.,Biochem. Biophys. Res. Comm.248: 174-179, 1998.
Deuel et al.,New England Journal of Medicine317: 236, 1987.
Floege et al.,J. Clin. Invest.92: 2952-2962, 1993.
Friedman,Seminars in Liver Disease19: 129-140, 1999.
Heldin et al.,Physiological Reviews79: 1283-1316, 1999.
Iredal et al.,J. Clinical Invest.102:538-549, 1998.
Isaka et al.,J. Clin. Invest.92: 2597-2601, 1993.
Isbrucker et al.,Tox. App. Pharmac.149: 120-126, 1998.
Johnson et al.,J. Exp. Med.175: 1413-1416, 1992.
Kallio et al.,Am. J. Respir. Crit. Care Med.160: 1324-1332, 1999.
LaRochelle et al.,Nature Cell Biol.3: 517-521, 2001.
Li et al.,Journal of Gastroenterology and Hepatology14: 618-633, 1999.
Li et al.,Nature Cell Biol.2: 302-309, 2000.
Mann et al.,Gut50:891-896, 2002.
Martinet et al.,New England Journal of Medicine317:202-209, 1987.
Pinzani et al.,Brit. J. Pharmac.119: 1117-1124, 1996.
Preaux et al.,Hepatology26: 315-322, 1997.
Rice et al., Am. J. Path. 155: 213-221, 1999.
Yagi et al.,Gen. Pharmac.31: 765-773, 1998.
Yi et al.,Am. J. Path.149: 539-548, 1996.
Yoshida et al.,Biochem. Biophys. Res. Comm.265: 503-508, 1999.
Yu et al.,Current Opin. Pharm.2:177-181, 2002.
Uutela et al.,Circulation103: 2242-2247, 2001.
Ouspenski Ilia
Sherbina Nicholas V.
ZymoGenetics Inc.
LandOfFree
Method of treating fibrosis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating fibrosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating fibrosis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4109274